Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04556331
Other study ID # 19/LO/1438 v7 01062020
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 25, 2020
Est. completion date January 31, 2021

Study information

Verified date September 2020
Source King's College London
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To pilot a brief group early intervention aimed at reducing or preventing the intergenerational transmission of anxiety, with parents whose child is between 12 and 47 months. To explore feasibility and acceptability of such an intervention with this population.


Description:

All participants will attend two group sessions of 'psychoeducation' (psychologically informed information about the topic of transmitting anxiety) and cognitive-behavioural strategies aimed at reducing the transmission of anxiety from parent to young child. The two sessions will be delivered online via Microsoft Teams, last 2 hours each and will run one week apart. Outcome and acceptability measures will be collected before, immediately after, and 6 weeks after the intervention. Feasibility data (e.g. drop-out rate) will be recorded.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date January 31, 2021
Est. primary completion date January 20, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - current or recent (within 2 years) primary diagnosis of anxiety disorder or self-report of clinically impairing anxiety problem within last 2 years, - parent of child aged 12-47 months at time of intervention, - access to an internet connection and smart phone/computer will be required to take part, - male or female, - resident in England, - and over the age of 18 Exclusion Criteria: - current severe co-morbid diagnoses, e.g. psychosis or acute suicidal risk (as the nature of the intervention is brief and in a group, the level of support needed to keep those with severe mental health disorders safe will not be available), - current alcohol or drugs misuse

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Parenting programme (cognitive behavioural) aimed at reducing generational transmission of anxiety
'Psychoeducation' (psychologically informed information about the topic of transmitting anxiety) and cognitive-behavioural strategies aimed at reducing the transmission of anxiety from parent to young child. These will be shared with a group of maximum 8 remotely delivered, in a didactic format.

Locations

Country Name City State
United Kingdom South London and Maudsley NHS Trust London

Sponsors (2)

Lead Sponsor Collaborator
King's College London South London and Maudsley NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants who consented to take part as percentage of those who expressed initial interest. Percentage of count (people consent to take part / people expressing interest in response to advertising). To indicate feasibility of larger trial. Total across recruitment period (up to 11 weeks, October 2020 to mid December 2020)
Primary Actual attendance at each session as percentage of expected attendance Percentage of count (people scheduled to attend each session / people who actually attended). To indicate feasibility of larger trial. Total across intervention period (up to 9 weeks, mid October 2020 to mid December 2020)
Primary Number of participants who provided completed questionnaire measures Percentage of recruited participants who completed questionnaire measures at each of the three collection timepoints. Total across intervention and 6 week follow-up period (up to 15 weeks, mid October 2020 to January 2021)
Primary Acceptability of Intervention Measure (AIM) and Intervention Appropriateness Measure (IAM) (Weiner, Lewis et al. 2017) Validated measure of acceptability of an intervention - Acceptability of Intervention Measure (AIM) and Intervention Appropriateness Measure (IAM) (Weiner, Lewis et al. 2017) Collected twice: immediately after intervention attendance (same day) and after 6 weeks.
Primary Open text questions about participants' views on the acceptability Open text questions to gather qualitative information about participants' perspectives on usefulness, accessibility and unintended negative consequences Collected twice: immediately after intervention attendance (same day) and after 6 weeks.
Secondary Change in score on Brief Infant Toddler Social and Emotional Assessment (Briggs-Gowan, Carter et al. 2002) Parent report measure of child social, emotional and behavioural difficulties. This is a 42-item parent-report screening tool validated with parents of children aged 12 to 47 months. Maximum score is 84 and minimum score is 0. The higher the score the worse the outcome. Collected three times to access change: Before intervention, immediately after end of intervention (same day) and 6 weeks after.
Secondary Change in score on Depression Anxiety Stress Scale (Henry and Crawford 2005) Parent report questionnaire measure of stress, anxiety and depression in parents. This is a 21-item scale. The minimum score is 0 and the maximum score is 63, higher score is a worse outcome. Collected three times to access change: Before intervention, immediately after end of intervention (same day) and 6 weeks after.
Secondary Bespoke questionnaire about self-reported use and confidence in behaviours specifically targeted in intervention. Bespoke questionnaire about 8 specific parenting behaviours targeted in the intervention, each rated on a 5-point Likert scale (4 are reverse scored). Minimum score is 0 and maximum score is 40. The higher the score the 'worse' the outcome. Collected three times to access change: Before intervention, immediately after end of intervention (same day) and 6 weeks after.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04579354 - Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Completed NCT03535805 - Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances N/A
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Active, not recruiting NCT05302167 - Molehill Mountain Feasibility Study. N/A
Completed NCT05881681 - A Mindfulness Approach to UA for Afro-descendants N/A
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT04961112 - Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits N/A
Recruiting NCT04612491 - Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
Completed NCT05980845 - The Effect Nature Sounds and Music on Hemodialysis Patients N/A
Recruiting NCT05449002 - Digital Single Session Intervention for Youth Mental Health N/A
Completed NCT05585749 - Virtual Reality Application on Pain Intensity and Anxiety Level in Endoscopy Patients N/A
Terminated NCT03272555 - WILD 5 Wellness: A 30-Day Intervention N/A
Recruiting NCT05997849 - Development of a Multiplatform Mental Health Mobile Tool N/A
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care